NDC 80631-100
NOVAVAX COVID-19 Vaccine, Adjuvanted
Nvx-cov2373
NOVAVAX COVID-19 Vaccine, Adjuvanted is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Novavax Inc.. The primary component is Nvx-cov2373.
| Product ID | 80631-100_24bdda28-6779-4319-8ef9-3d3d07df9b5a |
| NDC | 80631-100 |
| Product Type | Vaccine |
| Proprietary Name | NOVAVAX COVID-19 Vaccine, Adjuvanted |
| Generic Name | Nvx-cov2373 |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2021-04-23 |
| Marketing Category | UNAPPROVED DRUG OTHER / |
| Labeler Name | Novavax Inc. |
| Substance Name | NVX-COV2373 |
| Active Ingredient Strength | 5 ug/.5mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |